--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 7.200
- +0.210+3.00%
Close Sep 13 16:00 ET
- 7.200
- 0.0000.00%
Post 16:01 ET
310.66MMarket Cap-3389P/E (TTM)
7.293High7.010Low244.24KVolume7.040Open6.990Pre Close1.76MTurnover1.47%Turnover RatioLossP/E (Static)43.15MShares35.06052wk High0.93P/B120.06MFloat Cap6.30052wk Low--Dividend TTM16.68MShs Float35.060Historical High--Div YieldTTM4.04%Amplitude6.300Historical Low7.194Avg Price1Lot Size
Kyverna Therapeutics Key Stats
Kyverna Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Kyverna Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data